Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

653
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
653
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

310
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
310
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

393
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
393

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Statistical Framework for Measuring Reproducibility and Replicability of High-Throughput Experiments From Multiple Sources.

Statistics in medicine·2026
Same author

METTL3 promotes the progression of non-alcoholic fatty liver disease by mediating m6A methylation of FAS.

Scientific reports·2025
Same author

Interspecies regulatory landscapes and elements revealed by novel joint systematic integration of human and mouse blood cell epigenomes.

Genome research·2024
Same author

Dissecting heritability, environmental risk, and air pollution causal effects using > 50 million individuals in MarketScan.

Nature communications·2024
Same author

RETROFIT: Reference-free deconvolution of cell-type mixtures in spatial transcriptomics.

bioRxiv : the preprint server for biology·2023
Same author

Interspecies regulatory landscapes and elements revealed by novel joint systematic integration of human and mouse blood cell epigenomes.

bioRxiv : the preprint server for biology·2023

Related Experiment Video

Updated: Mar 26, 2026

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
14:58

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions

Published on: March 5, 2022

4.9K

A semi-parametric statistical model for integrating gene expression profiles across different platforms.

Yafei Lyu1, Qunhua Li2

  • 1The Huck Institute of Life Science, Pennsylvania State University, University Park, PA, 16802, USA. yul199@psu.edu.

BMC Bioinformatics
|January 29, 2016
PubMed
Summary
This summary is machine-generated.

Integrating RNA-sequencing (RNA-seq) and microarray data improves the detection of differentially expressed genes (DEGs). Our novel rank-based model enhances accuracy and identifies more biologically relevant genes across platforms.

More Related Videos

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress
05:22

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress

Published on: July 29, 2022

4.1K
Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

42.7K

Related Experiment Videos

Last Updated: Mar 26, 2026

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
14:58

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions

Published on: March 5, 2022

4.9K
Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress
05:22

Analyzing Multifactorial RNA-Seq Experiments with DiCoExpress

Published on: July 29, 2022

4.1K
Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
10:10

Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2

Published on: September 18, 2021

42.7K

Area of Science:

  • Genomics and Bioinformatics
  • Gene Expression Analysis
  • Systems Biology

Background:

  • Identifying differentially expressed genes (DEGs) is crucial for linking genotype to phenotype.
  • RNA-sequencing (RNA-seq) and microarray technologies are primary gene expression profiling methods.
  • Significant discrepancies exist between DEGs detected by RNA-seq and microarrays, necessitating data integration.

Purpose of the Study:

  • To develop a robust method for integrating RNA-seq and microarray data for improved DEG detection.
  • To enhance the power and reliability of identifying DEGs by leveraging cross-platform information.

Main Methods:

  • Proposed a rank-based semi-parametric model for DEG determination across different data sources.
  • Applied the model to integrate RNA-seq and microarray data, considering both significance and consistency.
  • Validated the method using simulation studies, MAQC/SEQC data, and a synthetic microRNA dataset.

Main Results:

  • The integration method effectively detects DEGs with moderate but consistent signals across platforms.
  • Demonstrated higher discriminatory power compared to existing methods like eBayes and DEseq in simulations and real data.
  • Identified a greater number of biologically relevant DEGs than commonly used meta-analysis approaches.

Conclusions:

  • The proposed integration method is robust to data noise and heterogeneity, adapting to various data structures.
  • Offers improved accuracy and biological relevance in DEG identification compared to standalone technologies and other integration methods.
  • Facilitates more reliable genotype-phenotype relationship studies through enhanced gene expression analysis.